Skip to content

PSYCHEMEDICS CORP

Delisted

CIK 806517fmd_09Y1AA2TK2DG83E1FGB8N1SE00Services · Services-Medical LaboratoriesTemplate: Standard

Coverage: Jan 01, 2009 to Dec 31, 2024, 60 periods

Income Statement · Annual · Millions · USD
Line itemFY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024
Total revenues27394043382125252220
Cost of revenue14182022211615161413
Gross profit1321202116510987
Research and development2112211111
Selling, general and administrative10101011121099108
Total operating expenses1111121313111010119
Operating income110883(6)0(1)(3)(2)
Interest expense0000000000
Interest and investment income––––––––––
Other non-operating income (expense)(0)(0)000(0)(1)0(1)(0)
Income before taxes110883(6)(1)(1)(3)(2)
Income tax expense(0)3232(2)(0)01(0)
Net income from continuing operations27652(4)(1)(1)(4)(2)
Net income27652(4)(1)(1)(4)(2)
PSYCHEMEDICS CORP financial statements · FinancialMD